ATLANTA, GA – – (Globe Newswire – May 1, 2024) – – Holzer & Holzer, LLC is investigating whether CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) complied with federal securities laws. On April 30, 2024, CVRx announced its financial and operating results for the first quarter of 2024, noting the “lower than anticipated revenue was due primarily to the performance of our U.S. Heart Failure business, where there was some disruption within our sales organization at the time of the CEO transition, which led to decreased productivity and some sales force turnover.” Following this news, the price of the Company’s stock dropped.

If you purchased CVRx stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/cvrx/ to discuss your legal rights.